A newborn lethal defect due to inactivation of retinaldehyde dehydrogenase type 3 is prevented by maternal retinoic acid treatment

  1. Valérie Dupé,
  2. Nicolas Matt,
  3. Jean-Marie Garnier,
  4. Pierre Chambon*,
  5. Manuel Mark, and
  6. Norbert B. Ghyselinck
  1. Institut de Génétique et de Biologie Moléculaire et Cellulaire, Institut Clinique de la Souris, Centre National de la Recherche Scientifique/Institut National de la Santé et de la Recherche Médicale/Université Louis Pasteur, Collège de France, BP10142, 67404 Illkirch Cedex, Communauté Urbaine de Strasbourg, France
  1. Contributed by Pierre Chambon, September 26, 2003

Abstract

The retinoic acid (RA) signal, produced locally from vitamin A by retinaldehyde dehydrogenase (Raldh) and transduced by the nuclear receptors for retinoids (RA receptor and 9-cis-RA receptor), is indispensable for ontogenesis and homeostasis of numerous tissues. We demonstrate that Raldh3 knockout in mouse suppresses RA synthesis and causes malformations restricted to ocular and nasal regions, which are similar to those observed in vitamin A-deficient fetuses and/or in retinoid receptor mutants. Raldh3 knockout notably causes choanal atresia (CA), which is responsible for respiratory distress and death of Raldh3-null mutants at birth. CA is due to persistence of nasal fins, whose rupture normally allows the communication between nasal and oral cavities. This malformation, which is similar to isolated congenital CA in humans and may result from impaired RA-controlled down-regulation of Fgf8 expression in nasal fins, can be prevented by a simple maternal treatment with RA.

Footnotes

  • * To whom correspondence should be addressed. E-mail: chambon{at}igbmc.u-strasbg.fr.

  • Abbreviations: CA, choanal atresia; En, embryonic day n; HG, Harderian gland; RA, retinoic acid; Raldh, retinaldehyde dehydrogenase; RAR, RA receptor; RXR, 9-cis-RA receptor; ES, embryonic stem.

« Previous | Next Article »Table of Contents